Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Bag-1L is a Stress-withstand Molecule Prevents the Downregulation of Mcl-1 and c-Raf Under Control of Heat Shock Proteins in Cisplatin Treated HeLa Cervix Cancer Cells

  • Ozfiliz, Pelin (Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University) ;
  • Arisan, Elif Damla (Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University) ;
  • Coker-Gurkan, Ajda (Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University) ;
  • Obakan, Pinar (Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University) ;
  • Eralp, Tugce Nur (Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University) ;
  • Dinler-Doganay, Gizem (Department of Molecular Biology and Genetics, Faculty of Sciences and Letters, Istanbul Technical University) ;
  • Palavan-Unsal, Narcin (Department of Molecular Biology and Genetics, Faculty of Science and Letters, Istanbul Kultur University)
  • Published : 2014.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Cisplatin, a DNA damaging agent, induces apoptosis through increasing DNA fragmentation. However, identification of intrinsic resistance molecules against Cisplatin is vital to estimate the success of therapy. Bag-1 (Bcl-2-associated anthanogene) is one anti-apoptotic protein involved in drug resistance impacting on therapeutic efficiency. Elevated levels of this protein are related with increase cell proliferation rates, motility and also cancer development. For this reason, we aimed to understand the role of Bag-1 expression in Cisplatin-induced apoptosis in HeLa cervix cancer cells. Cisplatin decreased cell viability in time- and dose-dependent manner in wt and Bag-1L+HeLa cells. Although, $10{\mu}M$ Cisplatin treatment induced cell death within 24h by activating caspases in wt cells, Bag-1L stable transfection protected cells against Cisplatin treatment. To assess the potential protective role of Bag-1, we first checked the expression profile of interacting anti-apoptotic partners of Bag-1. We found that forced Bag-1L expression prevented Cisplatin-induced apoptosis through acting on Mcl-1 expression, which was reduced after Cisplatin treatment in wt HeLa cells. This mechanism was also supported by the regulation of heat shock protein (Hsp) family members, Hsp90 and Hsp40, which were involved in the regulation Bag-1 interactome including several anti-apoptotic Bcl-2 family members and c-Raf.

Keywords

References

  1. Aveic S, Pigazzi M and Basso G (2011). BAG1: the guardian of anti-apoptotic proteins in acute myeloid leukemia. PLoS One, 6, e26097. https://doi.org/10.1371/journal.pone.0026097
  2. Barnes JD, Arhel NJ, Lee SS, et al (2005). Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis, 10, 301-11. https://doi.org/10.1007/s10495-005-0804-8
  3. Conway de Macario E, Macario AJ (2003). Molecular biology of stress genes in methanogens: potential for bioreactor technology. Adv Biochem Eng Biotechnol, 81, 95-150.
  4. Cutress RI, Townsend PA, Brimmell M, et al (2002). BAG-1 expression and function in human cancer. Br J Cancer, 87, 834-9. https://doi.org/10.1038/sj.bjc.6600538
  5. Dobbyn HC, Hill K, Hamilton TL, et al (2008). Regulation of BAG-1 IRES-mediated translation following chemotoxic stress. Oncogene, 27, 1167-74. https://doi.org/10.1038/sj.onc.1210723
  6. Fralix KD, Zhao S, Venkatasubbarao K and Freeman JW (2003). Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. J Cell Physiol, 194, 88-99. https://doi.org/10.1002/jcp.10192
  7. Gotz R, Wiese S, Takayama S, et al (2005). Bag1 is essential for differentiation and survival of hematopoietic and neuronal cells. Nat Neurosci, 8, 1169-78. https://doi.org/10.1038/nn1524
  8. Hassumi-Fukasawa MK, Miranda-Camargo FA, Zanetti BR, et al (2012). Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV). Pathol Oncol Res, 18, 929-37. https://doi.org/10.1007/s12253-012-9523-y
  9. House CM, Hancock NC, Moller A, et al (2006). Elucidation of the substrate binding site of Siah ubiquitin ligase. Structure, 14, 695-701. https://doi.org/10.1016/j.str.2005.12.013
  10. Jamshed A, Hussain R, Iqbal H (2014). Gemcitabine and Cisplatin followed by chemo-radiation for advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev, 15, 899-904. https://doi.org/10.7314/APJCP.2014.15.2.899
  11. King FW, Wawrzynow A, Hohfeld J, Zylicz M (2001). Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53. Embo J, 20, 6297-305. https://doi.org/10.1093/emboj/20.22.6297
  12. Liman J, Ganesan S, Dohm CP, et al (2005). Interaction of BAG1 and Hsp70 mediates neuroprotectivity and increases chaperone activity. Mol Cell Biol, 25, 3715-25. https://doi.org/10.1128/MCB.25.9.3715-3725.2005
  13. Liu H, Liang Y, Li Y, et al (2010). Gene silencing of BAG-1 modulates apoptotic genes and sensitizes lung cancer cell lines to cisplatin-induced apoptosis. Cancer Biol Ther, 9, 832-40. https://doi.org/10.4161/cbt.9.10.11589
  14. Newman DJ, Cragg GM (2004). Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr Med Chem, 11, 1693-713. https://doi.org/10.2174/0929867043364982
  15. Noguchi T, Takeno S, Shibata T, et al (2003). Nuclear BAG-1 expression is a biomarker of poor prognosis in esophageal squamous cell carcinoma. Dis Esophagus, 16, 107-11. https://doi.org/10.1046/j.1442-2050.2003.00307.x
  16. Nollen EA, Brunsting JF, Song J, et al (2000). Bag1 functions in vivo as a negative regulator of Hsp70 chaperone activity. Mol Cell Biol, 20, 1083-8. https://doi.org/10.1128/MCB.20.3.1083-1088.2000
  17. Packham G, Brimmell M, Cleveland JL (1997). Mammalian cells express two differently localized Bag-1 isoforms generated by alternative translation initiation. Biochem J, 328, 807-13.
  18. Roy M, Mukherjee S (2014). Reversal of resistance towards Cisplatin by curcumin in cervical cancer cells. Asian Pac J Cancer Prev, 15, 1403-10. https://doi.org/10.7314/APJCP.2014.15.3.1403
  19. Rushdan MN, Tay EH, Khoo-Tan HS, et al (2004). Tailoring the field and indication of adjuvant pelvic radiation for patients with FIGO stage Ib lymph nodes-negative cervical carcinoma following radical surgery based on the GOG score--a pilot study. Ann Acad Med Singapore, 33, 467-72.
  20. Schwickart M, Huang X, Lill JR, et al (2010). Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival. Nature, 463, 103-7. https://doi.org/10.1038/nature08646
  21. Song HY, Deng XH, Yuan GY, et al (2014). Expression of bcl-2 and p53 in induction of esophageal cancer cell apoptosis by ECRG2 in combination with Cisplatin. Asian Pac J Cancer Prev, 15, 1397-401. https://doi.org/10.7314/APJCP.2014.15.3.1397
  22. Song J, Takeda M, Morimoto RI (2001). Bag1-Hsp70 mediates a physiological stress signalling pathway that regulates Raf-1/ERK and cell growth. Nat Cell Biol, 3, 276-82. https://doi.org/10.1038/35060068
  23. Takayama S, Bimston DN, Matsuzawa S, et al (1997). BAG-1 modulates the chaperone activity of Hsp70/Hsc70. Embo J, 16, 4887-96. https://doi.org/10.1093/emboj/16.16.4887
  24. Takayama S, Krajewski S, Krajewska M, et al (1998). Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res, 58, 3116-31.
  25. Takayama S, Sato T, Krajewski S, et al (1995). Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell, 80, 279-84. https://doi.org/10.1016/0092-8674(95)90410-7
  26. Townsend PA, Cutress RI, Sharp A, et al (2003). BAG-1 prevents stress-induced long-term growth inhibition in breast cancer cells via a chaperone-dependent pathway. Cancer Res, 63, 4150-7.
  27. Wang HG, Reed JC (1998). Bc1-2, Raf-1 and mitochondrial regulation of apoptosis. Biofactors, 8, 13-6. https://doi.org/10.1002/biof.5520080103
  28. Wang HG, Takayama S, Rapp UR, Reed JC (1996). Bcl-2 interacting protein, BAG-1, binds to and activates the kinase Raf-1. Proc Natl Acad Sci USA, 93, 7063-8. https://doi.org/10.1073/pnas.93.14.7063
  29. Zhang YX, Abliz G, Ye WJ, et al (2014). Mechanisms of hela cell apoptosis induced by abnormal savda munziq total phenolics combined with chemotherapeutic agents. Asian Pac J Cancer Prev, 15, 743-7. https://doi.org/10.7314/APJCP.2014.15.2.743
  30. Zheng HC, Xu XY, Xing YN, et al (2010). Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas. Hum Pathol, 41, 724-36. https://doi.org/10.1016/j.humpath.2009.10.017
  31. Zhou RP, Chen G, Shen ZL, Pan LQ (2014). Cinobufacin suppresses cell proliferation via miR-494 in BGC- 823 gastric cancer cells. Asian Pac J Cancer Prev, 15, 1241-5. https://doi.org/10.7314/APJCP.2014.15.3.1241
  32. Zighelboim I, Wright JD, Gao F, et al (2013). Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer. Gynecol Oncol, 130, 64-8. https://doi.org/10.1016/j.ygyno.2013.04.009
  33. Zylicz M, King FW, Wawrzynow A (2001). Hsp70 interactions with the p53 tumour suppressor protein. EMBO J, 20, 4634-8. https://doi.org/10.1093/emboj/20.17.4634

Cited by

  1. Silencing Bag-1 gene via magnetic gold nanoparticle-delivered siRNA plasmid for colorectal cancer therapy in vivo and in vitro vol.37, pp.8, 2016, https://doi.org/10.1007/s13277-016-4926-0
  2. Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers vol.10, pp.2, 2018, https://doi.org/10.3390/pharmaceutics10020065